Rankings
▼
Calendar
NXTC FY 2021 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$36M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$71M
Net Income
-$69M
EPS (Diluted)
$-30.15
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$60M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$242M
Total Liabilities
$9M
Stockholders' Equity
$233M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$22M
-100.0%
Gross Profit
$0
-$24M
+100.0%
Operating Income
-$71M
-$41M
-71.7%
Net Income
-$69M
-$37M
-89.6%
← Q4 2020
All Quarters
Q1 2021 →